Back
Columbia Seligman Premium Technology Growth Fund Vs. Corcept Therapeutics Industry Stock Comparison
Buy
82
STK
Columbia Seligman Premium Technology Growth Fund
Last Price:
33.76
Seasonality Move:
5.08%
Buy
87
CORT
Corcept Therapeutics
Last Price:
59.57
Seasonality Move:
3.97%
Buy
82
Columbia Seligman Premium Technology Growth Fund (STK)
is a Buy
Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?
- The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $33.76. The Score for STK is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- STK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
STK Stock Price Chart
What is Columbia Seligman Premium Technology Growth Fund's stock price today?
-
The Columbia Seligman Premium Technology Growth Fund share price today is $33.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STK is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
STK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 60.92 | Buy |
| Chaikin Money Flow: | 3026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.83 - 33.59) | Buy |
| Bollinger Bands (100): | (31.88 - 33.68) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.95 | Buy |
| Relative Strength Index (14 RSI): | 80.63 | Buy |
| Chaikin Money Flow: | 759215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.11 - 51.89) | Buy |
| Bollinger Bands (100): | (31.7 - 45.68) | Buy |
STK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.08 | Buy |
| 20-day SMA: | 33.17 | Buy |
| 50-day SMA: | 32.82 | Buy |
| 200-day SMA: | 32.44 | Buy |
| 8-day EMA: | 33.27 | Buy |
| 20-day EMA: | 33.14 | Buy |
| 50-day EMA: | 32.94 | Buy |
| 200-day EMA: | 32.12 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.72 | Buy |
| 20-day SMA: | 49.28 | Buy |
| 50-day SMA: | 44.07 | Buy |
| 200-day SMA: | 32 | Buy |
| 8-day EMA: | 53.06 | Buy |
| 20-day EMA: | 49.83 | Buy |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 35.31 | Buy |
Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Columbia Seligman Premium Technology Growth Fund Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||